-
Psoriasis is a long-lasting autoimmune disease characterized by patches of skin becoming inflamed, itchy, dry, and scaly. While predominantly determined by genetic and immune influences, dermatologists are increasingly recognizing lifestyle modifiers – particularly, diet – in the management of symptoms.
-
Hair care tips: Not all flakes are the same. Although dandruff is typically harmless and responds quickly to treatment, flaky skin that persists, and is accompanied by redness and itching may be caused by scalp psoriasis, a chronic condition that requires a visit to your doctor.
-
Psoriasis, a long-term inflammatory skin disease, may occur due to certain genetic factors, that may combine with triggers to produce the condition. Better control of symptoms together with reduced long-term risks becomes possible through understanding the different types of psoriasis and their symptoms and treatment methods.
-
If psoriasis runs in your family, you may carry the genes—but lifestyle choices and early care can make all the difference in prevention and control
-
A UK study of over 330,000 people shows abdominal fat, more than overall body fat, is strongly linked to psoriasis, especially in women. Health experts now advise focusing on waist size, core strength and lifestyle tweaks to lower skin inflammation and reduce disease risk.
-
Psoriasis is a condition that speeds up the life cycle of skin cells, causing them to build up rapidly on the surface of the skin. This buildup of cells leads to scaling on the skin’s surface. Here's a guide to understanding types, triggers, and available treatment of this chronic autoimmune condition.
-
Acne, eczema, psoriasis and dermatitis are skin conditions that become worse because of stress. Follow these stress-reducing techniques into your routine to take care of your mental health, and keep yourself away from these skin conditions.
-
Neglecting foot care can result in painful and unsightly cracked heels which can lead to infections if left untreated. Cracked heels can stem from factors like prolonged standing, dry environments, or skin conditions like eczema and psoriasis. Follow these home remedies to take care of your feet during winter.
-
After phase 2 results, the company's CEO said the drug will not add desirable benefit to patients with moderate to severe, psoriasis, hence, the firm decided to stop the clinical development of AUR101 as an oral drug in psoriasis.
-
One of the company's wholly-owned subsidiaries and Hikma Pharmaceuticals have entered into the agreement for Ilumya, Sun Pharma said in a filing to BSE.
-
Pharmaceutical major Lupin Ltd gets USFDA nod for a generic psoriasis treatment solution.
-
Apremilast, which is a phosphodiesterase 4 (PDE4) inhibitor indicated for the treatment of moderate to severe Psoriasis, will revolutionise the treatment of Psoriasis, Glenmark Pharmaceuticals said in a statement.
-
Tildrakizumab is an investigational IL-23p19 inhibitor currently being evaluated in patients with moderate-to-severe plaque psoriasis.
-
Sun Pharma has completed a 12 weeks trial of its psoriasis drug, MK 3222, but needs 52-124 weeks data to apply for a license with the US FDA, says Surajit Pal, pharma analyst at Prabhudas Lilladher.
-
The Hyderabad-based firm and its subsidiary, Promius Pharma LLC have filed three new drug applications with the US Food and Drug Administration (USFDA), Dr Reddy's Laboratories Ltd said in a statement.
-
Biocon CMD Kiran Mazumdar-Shaw said the company‘s research efforts are focused on a number of programs that deliver drugs that women can benefit from.
